Phibro Animal Health (NASDAQ:PAHC) is engaged in the development, manufacture, and marketing of a wide range of animal health and nutrition products. The company's portfolio includes medicated feed additives, nutritional specialty products, and vaccines that cater to livestock, including poultry, swine, beef, and dairy cattle, as well as aquaculture. Strategically committed to enhancing animal health and productivity, Phibro aims to contribute to a more sustainable and efficient global food supply. Through ongoing research and development efforts, the company focuses on innovation to address the evolving needs of animal health and nutrition, striving for excellence in its projects and operations to deliver value to customers and shareholders alike.